Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Madeleine D. Burns, Brittany P. Boribong, Yannic C. Bartsch, Maggie Loiselle, Kerri J. St. Denis, Maegan L. Sheehan, Jessica W. Chen, Jameson P. Davis, Rosiane Lima, Andrea G. Edlow, Alessio Fasano, Alejandro B. Balazs, Galit Alter, Lael M. Yonker
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2022-03-01
Saila:Vaccines
Gaiak:
SARS-CoV-2
COVID-19
pediatrics
adolescents
vaccines
boosters
Sarrera elektronikoa:https://www.mdpi.com/2076-393X/10/4/492
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak